Vanda Pharmaceuticals
VNDA
#8337
Rank
A$0.43 B
Marketcap
A$7.26
Share price
-1.54%
Change (1 day)
12.25%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -A$0.24 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$57.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.24 Billion10.92%
2025 -A$0.22 Billion271.79%
2024 -A$57.88 Million191.43%
2023 -A$19.86 Million-320.45%
2022 A$9 M-84.99%
2021 A$60.01 M54.8%
2020 A$38.77 M19.42%
2019 A$32.46 M4.93%
2018 A$30.94 M-228.6%
2017 -A$24.06 Million-8.98%
2016 -A$26.44 Million-53.79%
2015 -A$57.2 Million-30.18%
2014 -A$81.93 Million173.08%
2013 -A$30 Million-25.33%
2012 -A$40.18 Million163.61%
2011 -A$15.25 Million-221.15%
2010 A$12.57 M-124.53%
2009 -A$51.29 Million-29.44%
2008 -A$72.69 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$93.53 Million170.55%
2005 -A$34.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.97 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.46 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.07 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.30 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.72 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.66 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA